Heribert Bohlen

5.0k total citations
81 papers, 3.7k citations indexed

About

Heribert Bohlen is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Heribert Bohlen has authored 81 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 30 papers in Molecular Biology and 26 papers in Oncology. Recurrent topics in Heribert Bohlen's work include Monoclonal and Polyclonal Antibodies Research (26 papers), Lymphoma Diagnosis and Treatment (17 papers) and CAR-T cell therapy research (13 papers). Heribert Bohlen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (26 papers), Lymphoma Diagnosis and Treatment (17 papers) and CAR-T cell therapy research (13 papers). Heribert Bohlen collaborates with scholars based in Germany, United States and Netherlands. Heribert Bohlen's co-authors include Volker Diehl, Hans Tesch, Oliver Manzke, Bernd K. Fleischmann, Wilhelm Bloch, Juergen Hescheler, Martin R. Weihrauch, Eugen Kolossov, Dieter Kube and Ralf Kettenhofen and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Heribert Bohlen

77 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heribert Bohlen Germany 34 1.3k 1.1k 797 784 774 81 3.7k
Carole Perruzzi United States 27 4.8k 3.7× 560 0.5× 960 1.2× 1.3k 1.6× 313 0.4× 31 7.9k
Elizabeth A. Wayner United States 32 2.2k 1.7× 1.3k 1.2× 1.0k 1.3× 614 0.8× 158 0.2× 57 6.2k
Pu Zhang China 36 3.1k 2.4× 1.5k 1.4× 242 0.3× 992 1.3× 308 0.4× 163 6.5k
Gero Brockhoff Germany 32 1.2k 0.9× 518 0.5× 478 0.6× 1.5k 1.9× 282 0.4× 113 3.5k
Rupert Hallmann Germany 36 1.8k 1.4× 2.0k 1.8× 324 0.4× 838 1.1× 152 0.2× 51 5.4k
Bronislaw Pytowski United States 37 3.5k 2.7× 790 0.7× 679 0.9× 3.6k 4.5× 286 0.4× 61 6.5k
Yuti Chernajovsky United Kingdom 36 1.9k 1.5× 2.0k 1.8× 392 0.5× 1.1k 1.4× 167 0.2× 125 4.5k
Deborah L. French United States 38 2.4k 1.9× 1.0k 0.9× 299 0.4× 741 0.9× 117 0.2× 134 5.3k
Carlos Cabañas Spain 43 2.7k 2.1× 2.1k 1.9× 533 0.7× 887 1.1× 133 0.2× 101 6.2k
Richard C. Bates United States 32 2.2k 1.7× 568 0.5× 356 0.4× 1.6k 2.0× 260 0.3× 51 4.3k

Countries citing papers authored by Heribert Bohlen

Since Specialization
Citations

This map shows the geographic impact of Heribert Bohlen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heribert Bohlen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heribert Bohlen more than expected).

Fields of papers citing papers by Heribert Bohlen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heribert Bohlen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heribert Bohlen. The network helps show where Heribert Bohlen may publish in the future.

Co-authorship network of co-authors of Heribert Bohlen

This figure shows the co-authorship network connecting the top 25 collaborators of Heribert Bohlen. A scholar is included among the top collaborators of Heribert Bohlen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heribert Bohlen. Heribert Bohlen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Becker, Nadine, Sonja Stoelzle‐Feix, Patrick Mumm, et al.. (2014). Minimized Cell Usage for Stem Cell-Derived and Primary Cells on an Automated Patch Clamp System. Biophysical Journal. 106(2). 135a–135a. 33 indexed citations
2.
Stoelzle, Sonja, Ralf Kettenhofen, Eugen Kolossov, et al.. (2011). Automated Patch Clamp on mESC-Derived Cardiomyocytes for Cardiotoxicity Prediction. SLAS DISCOVERY. 16(8). 910–916. 44 indexed citations
3.
Kettenhofen, Ralf & Heribert Bohlen. (2008). Preclinical assessment of cardiac toxicity. Drug Discovery Today. 13(15-16). 702–707. 33 indexed citations
4.
Hescheler, Juergen, Marcel Halbach, Ulrich Egert, et al.. (2004). Determination of electrical properties of ES cell-derived cardiomyocytes using MEAs. Journal of Electrocardiology. 37. 110–116. 60 indexed citations
5.
Schwengberg, Silke, Heribert Bohlen, N. Kleinsasser, et al.. (2004). In vitro embryotoxicity assessment with dental restorative materials. Journal of Dentistry. 33(1). 49–55. 108 indexed citations
6.
Schultze, Joachim L. & Heribert Bohlen. (2002). Influence of Genomics on Cancer Vaccine Development - from Guess to Prediction. Current Pharmaceutical Design. 8(19). 1735–1748.
7.
Mathiak, Guenther, Lewis F. Neville, Guido Grass, et al.. (2001). CHEMOKINES AND INTERLEUKIN-18 ARE UP-REGULATED IN BRONCHOALVEOLAR LAVAGE FLUID BUT NOT IN SERUM OF SEPTIC SURGICAL ICU PATIENTS. Shock. 15(3). 176–180. 15 indexed citations
8.
Weihrauch, Martin R., Volker Diehl, & Heribert Bohlen. (2001). Künstliche Süßstoffe – Haben sie ein kanzerogenes Potential?. Medizinische Klinik. 96(11). 670–675. 15 indexed citations
9.
Manzke, Oliver, Hans Tesch, Johann Lorenzen, Volker Diehl, & Heribert Bohlen. (2001). Locoregional treatment of low-grade B-cell lymphoma with CD3�CD19 bispecific antibodies and CD28 costimulation: II. Assessment of cellular immune responses. International Journal of Cancer. 91(4). 516–522. 22 indexed citations
10.
Bohlen, Heribert, Marcus M. Kessler, M. Sextro, Volker Diehl, & Hans Tesch. (2000). Poor clinical outcome of patients with Hodgkin's Disease and elevated interleukin-10 serum levels. Annals of Hematology. 79(3). 110–113. 82 indexed citations
11.
Manzke, Oliver, Kevin Fitzgerald, Philipp Holliger, et al.. (1999). CD3� anti-nitrophenyl bispecific diabodies: Universal immunotherapeutic tools for retargeting T cells to tumors. International Journal of Cancer. 82(5). 700–708. 12 indexed citations
12.
Manzke, Oliver, et al.. (1999). CD3xCD19 bispecific antibodies and CD28 bivalent antibodies enhance T-cell reactivity against autologous leukemic cells in pediatric B-ALL bone marrow. International Journal of Cancer. 80(5). 715–722. 18 indexed citations
13.
Kornacker, Martin, Martina Vockerodt, Hans Tesch, et al.. (1999). Detection of a Hodgkin/Reed‐Sternberg cell specific immunoglobulin gene rearrangement in the serum DNA of a patient with Hodgkin's disease. British Journal of Haematology. 106(2). 528–531. 16 indexed citations
14.
Bohlen, Heribert, et al.. (1998). Inhibition of interleukin-8 synthesis by intraarticular methotrexate therapy in patientes with rheumatoid arthritis. Zeitschrift für Rheumatologie. 57(2). 95–100. 15 indexed citations
15.
Polack, Axel, Michael Pawlita, Heribert Bohlen, et al.. (1997). Suitability of Epstein–Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells. Gene Therapy. 4(2). 82–92. 32 indexed citations
16.
Dijk, A. van, et al.. (1997). B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease. British Journal of Cancer. 76(9). 1163–1169. 26 indexed citations
17.
Westermann, Frank, Dieter Kube, Birgit Haier, et al.. (1996). Interleukin 10 inhibits cytokine production of human AML cells. Annals of Oncology. 7(4). 397–404. 23 indexed citations
18.
Gorschlüter, Marcus, Heribert Bohlen, Dirk Hasenclever, Volker Diehl, & Hans Tesch. (1995). Serum cytokine levels correlate with clinical parameters in Hodgkin’s disease. Annals of Oncology. 6(5). 477–482. 50 indexed citations
19.
Gause, Angela, et al.. (1994). Impaired Antibody Levels to Tetanus Toxoid and Pneumococcal Polysaccharides in Acute Leukemias. Leukemia & lymphoma. 16(1-2). 89–96. 8 indexed citations
20.
Pohl, Christoph, Ralf W. Denfeld, Wolfram Jung, et al.. (1993). CD30‐antigen‐specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: Potential use for the treatment of hodgkin's lymphoma. International Journal of Cancer. 54(5). 820–827. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carole Perruzzi Breakdown of academic impact, for papers by Elizabeth A. Wayner Breakdown of academic impact, for papers by Pu Zhang Breakdown of academic impact, for papers by Gero Brockhoff Breakdown of academic impact, for papers by Rupert Hallmann Breakdown of academic impact, for papers by Bronislaw Pytowski Breakdown of academic impact, for papers by Yuti Chernajovsky Breakdown of academic impact, for papers by Deborah L. French Breakdown of academic impact, for papers by Carlos Cabañas Breakdown of academic impact, for papers by Richard C. Bates
Rankless by CCL
2026